BlackRock International Fund Q4 2024 Commentary
2025-03-24 14:50:00 ET
Summary
- BlackRock International Fund posted returns of -4.79% (Institutional shares) and -4.81% (Investor A shares, without sales charge) for the fourth quarter of 2024.
- The top contributors were Sony, Marvell, and Recruit. Novo Nordisk performed weakly due to disappointing Phase 3 results for key anti-obesity drug candidate Cagrisema.
- International markets were weak during the quarter. The U.S. dollar strengthened by 5.6% due to higher Treasury yields following the U.S. election.
Average annual total returns (%) as of 12/31/24
4Q24 (not annualized) | YTD (not annualized) | 1 Year | 3 Year | 5 Years | 10 Years | |
Institutional | -4.79 | 0.46 | 0.46 | -3.06 | 3.94 | 4.92 |
Investor A (Without Sales Charge) | -4.81 | 0.22 | 0.22 | -3.31 | 3.68 | 4.61 |
Investor A (With Sales Charge) | -9.80 | -5.04 | -5.04 | -5.03 | 2.57 | 4.05 |
MSCI All Country World ex-U.S. 2 | -8.01 | 7.50 | 7.50 | — | — | — |
Read the full article on Seeking Alpha
For further details see:
BlackRock International Fund Q4 2024 CommentaryNASDAQ: NPCPF
NPCPF Trading
0.0% G/L:
$6.22 Last:
2,395 Volume:
$6.22 Open:



